TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
SUPN

Supernus Pharmaceuticals Inc

Healthcare · Drug Manufacturers - Specialty & Generic

42.90$ +3.7% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Supernus Pharmaceuticals Inc (SUPN): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/03/2026.

Next report 11/03/2026
Last report 08/03/2026
Earnings surprise by quarter (%)
Q3 23 · 200.0 % 23 Q4 23 · 61.8 % 23 Q1 24 · -36.8 % 24 Q2 24 · 71.8 % 24 Q3 24 · 150.0 % 24 Q4 24 · 5.4 % 24 Q1 25 · 18.9 % 25 Q2 25 · 93.6 % 25 Q3 25 · -25.6 % 25 Q4 25 · 115.2 % 25 Q1 26 · -25.0 % 26 Q2 26 · 30.0 % 26

EPS estimate beaten

Full history 43 of 57 quarters (75%)
Last 16 quarters 12 of 16 quarters (75%)

Earnings Call Transcripts

Search all transcripts →

  • 05/05/2026 Earnings Call Q1 2026 Open →
  • 02/25/2026 Earnings Call Q4 2025 Open →
  • 11/05/2025 Earnings Call Q3 2025 Open →
  • 08/05/2025 Earnings Call Q2 2025 Open →
  • 05/06/2025 Earnings Call Q1 2025 Open →
  • 02/25/2025 Earnings Call Q4 2024 Open →
  • 11/04/2024 Earnings Call Q3 2024 Open →
  • 08/06/2024 Earnings Call Q2 2024 Open →
  • 05/08/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/03/2026 SUPERNUS PHARMACEUTICALS, INC. (SUPN): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/03/2026 SUPERNUS PHARMACEUTICALS, INC. (SUPN): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/03/2026 SUPERNUS PHARMACEUTICALS, INC. (SUPN): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/03/2026 SUPERNUS PHARMACEUTICALS, INC. (SUPN): Entry into a Material Definitive Agreement; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/22/2026 SUPERNUS PHARMACEUTICALS, INC. (SUPN): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?